What distinguishes neurotoxicity or ICANS from other CAR T-cell therapy side effects?
Answer
It directly affects the central nervous system
ICANS, or Immune Effector Cell-Associated Neurotoxicity Syndrome, is a specific type of toxicity that directly involves the central nervous system. Unlike generalized systemic inflammation, which primarily impacts blood pressure and organ function, neurotoxicity manifests through neurological symptoms such as confusion, severe headaches, seizures, and in extreme cases, cerebral edema. This distinct mechanism of injury necessitates specialized care in hospital centers capable of providing intensive monitoring.
Related Questions
What is the defining characteristic of CAR T-cell therapy?Which protein serves as the common target for CAR T-cell therapy in B-cell cancers?What is the primary function of the leukapheresis procedure?What role does a vector derived from a deactivated virus play in T-cell engineering?How does TCR cell therapy differ from CAR T-cell therapy regarding antigen recognition?What triggers the onset of Cytokine Release Syndrome or CRS?What distinguishes neurotoxicity or ICANS from other CAR T-cell therapy side effects?What is the purpose of bridging chemotherapy during the waiting period?What defines the expansion phase in the CAR T-cell manufacturing protocol?What is the intended advantage of developing off-the-shelf allogeneic products?